Transcriptional Reprogramming and Inhibition of Tumor-propagating Stem-like Cells by EC (cas 14344-48-0)-8042 in ERG-positive Prostate Cancer
-
Add time:08/02/2019 Source:sciencedirect.com
BackgroundThe TMPRSS2-ERG gene fusion is the most frequent genetic rearrangement in prostate cancers and results in broad transcriptional reprogramming and major phenotypic changes. Interaction and cooperation of ERG and SP1 may be instrumental in sustaining the tumorigenic and metastatic phenotype and could represent a potential vulnerability in ERG fusion–positive tumors.
We also recommend Trading Suppliers and Manufacturers of EC (cas 14344-48-0). Pls Click Website Link as below: cas 14344-48-0 suppliers
Prev:Characterization of stress degradation products of duloxetine hydrochloride employing LC–UV/PDA and LC–MS/TOF studies
Next:EC (cas 14344-48-0)-tractability of approximation problems in function spaces defined over products of simplices) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- EU DEMO EC (cas 14344-48-0) system preliminary conceptual design08/10/2019
- Design of the ITER EC (cas 14344-48-0) upper launcher nuclear shielding08/09/2019
- DNA scaffold nanoparticles coated with HPMC/EC (cas 14344-48-0) for oral delivery08/08/2019
- Plasma equilibrium based on EC (cas 14344-48-0)-driven current profile with toroidal rotation on QUEST08/07/2019
- Heteroscedastic stratified two-way EC (cas 14344-48-0) models of single equations and SUR systems08/06/2019
- Demonstration of synchronous control of EC (cas 14344-48-0) TL switch and gyrotron for ITER EC (cas 14344-48-0) system08/05/2019
- Enhanced operation of the Eu EC (cas 14344-48-0) test facility08/04/2019
- EC (cas 14344-48-0)-tractability of approximation problems in function spaces defined over products of simplices08/03/2019
